A new trial at Royal Brompton Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust, is using microwave energy to destroy lung cancers in hard-to-reach locations in the lungs.
Professor Pallav Shah and Dr Christopher Orton, of the Royal Brompton Hospital, have become the first specialists in the world to perform a robotic guided microwave ablation of lung tissue in the same sitting as a diagnostic procedure. Creo's MicroBlate Flex device was used to perform the procedure.
In a recent announcement, Professor Shah and his team reported that microwave ablation was used to ablate a 27mm cancerous nodule in a patient's lung. The procedure took place at the Royal Brompton Hospital in London and is reported to have taken 3 minutes.
Dr Orton commented:
The potential to combine the diagnosis, staging and treatment of lung cancer in one procedure offers significant benefit to patients.
Craig Gulliford, Chief Executive Officer of Creo, said:
Creo has been pioneering minimally invasive surgical endoscopy for pre-cancer and cancer patients for years, and implementing our technology into robotic application is a key goal for us as the adoption of this technology continues to grow exponentially.
We are incredibly proud that our MicroBlate Flex technology has been able to make this world-first possible. The potential for these technologies to combine precise robotically guided lung cancer diagnosis with the ablation of cancerous tissue in one session is transformational. Not only could this dramatically improve outcomes for lung cancer patients, but it has the potential to do away with long and worrying delays between diagnosis and treatment. This is the beginning of an exciting program and the team have done a terrific job in reaching this point.
For press enquiries please contact media@creomedical.com. For all other enquiries please visit our Contact page.